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Summary
Long-term mechanical circulatory support has become a valid treatment option for 
end stage heart failure. In selected patients’ cases, this therapeutic option has been pro-
ven to improve survival, both as a bridge to transplant and as a destination therapy. In 
this article, we address implantation technique, strategies to prevent excessive bleeding, 
right heart failure, and driveline and pocket infection.
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Devices
Left ventricular assist devices (LVADs) are classified as either pulsatile or non-
pulsatile (continuous), based on the nature of the flow they produce. The pulsatile 
pumps have a mechanical pusher plate or sac that propels blood mechanically or 
pneumatically, whereas continuous flow pumps are rotary devices that establish 
continuous flow. Furthermore, continuous flow pumps are either centrifugal or axi-
al flow, where centrifugal pumps utilize a rotating disk that spins blood in a circular 
motion to create centrifugal force to pump blood; an axial flow pump consists of a 
spinning rotor that propels blood alongside the native circulation.
Pulsatile devices, such as Thoratec VAD system, allow left, right, or bi-ventricular 
assistance to patients with end stage heart failure. The VAD are prosthetic ventric-
les, which are composed of blood sacs inside a hard plastic casing. A pressure/vacu-
um system allows the air  to enter the casing around the blood sac. This expansion 
and contraction of the air sacs allows the VAD to fill and eject blood, and provides 
the body with blood flow similar to that of the native heart. It has been FDA-appro-
ved both as a bridge-to-transplant therapy and for post-cardiotomy recovery from 
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open-heart surgery. Thoractec pVAD is a paracorporeal device – the pump chamber 
is outside the body, thus allowing the use on patients of small body size.
Most of the currently widely implanted devices are the axial-flow rotary devi-
ces (such as Thoratec Heartmate II; BerlinHeart INCOR; MicroMed DeBakey VAD; 
HeartWare HVAD) that possess several advantages over the older devices, including 
their small size, ease of implant, durability and silent operation. However, since the 
device implant still requires open-heart surgery and the use of the cardiopulmo-
nary bypass, patients may potentially develop complications related to the surgery.
Surgical technique
Although there is a whole range of different devices available on the market, the 
operative technique has been standardized with the following steps: mediastinal 
exposure with the creation of the device pocket; outflow graft anastomosis to the 
ascending aorta; placement of device inflow cannula at the left ventricular apex; de-
airing of the device; and device start followed by weaning from cardiopulmonary 
bypass (CPB) support.
The patient is prepared for open-heart cardiopulmonary bypass surgery as 
usual. The sternum is opened, and prior to heparinization, a pre-peritoneal LVAD 
pocket is created in the left upper quadrant. We try to develop the plane above the 
posterior rectus sheet and to size the pocket according to the device mannequin. It is 
of utmost importance to perform meticulous pocket hemostasis, because the pocket 
will be inaccessible after the definitive pump placement. 
To minimize the bypass time, it is possible to perform aortic anastomosis first with 
the use of aortic side-biting clamp. The graft is precloted, measured, trimmed, and sewn 
using 4-0 Prolene sutures with additional reinforcing Teflon strips. To prevent additio-
nal bleeding, fibrin glue is generously applied over the entire anastomosis line.
The heart is cannulated in the usual fashion, via the aorta and a single atrial 
venous cannula. CPB is instituted to allow the placement of the left ventricular api-
cal inflow cannula. We tend to do it in normothermia on a beating heart, with the 
operating field being flooded with carbon dioxide. The left ventricular vent is placed 
via the right superior pulmonary vein to both maintain a dry operative field and 
additionally help de-airing the heart.
The heart is lifted and a specialized coring knife is used to create the apical core. 
Exact site and direction of coring should be carefully selected to avoid deviation 
into the septum. Like in all axial-flow pumps, there is a risk of generating negati-
ve intraventricular pressure and collapsing the ventricle. Therefore, inflow cannula 
positioning and ventricular preload are crucial to avoid potential suction events. 
Trabeculations that may impinge on the cannula should be excised and possible 
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mural thrombi completely removed. Afterwards, 12-15 braided polypropylene 2-0 
sutures with medium-sized Teflon pledgets are equally spaced around the ventricu-
lar opening, passed through the sewing ring of the inflow cuff, and tied. Additional 
running Prolene 3-0 suture with circular Teflon strip and abundant fibrin glue can 
be used for the reinforcement of anastomosis. The cannula is brought down to the 
ventricle, secured to inflow cuff and attached to the LVAD body. 
The LVAD driveline is passed through the abdominal rectus muscle and subcu-
taneous tissue using the appropriate stylet to the skin of the upper abdomen. We 
routinely try to lengthen the subcutaneous part of the driveline by passing it first 
through the auxiliary skin incision at the right upper quadrant, and afterwards to 
the final exit spot, slightly to the left from the median line and above the patient’s 
belt line. By this maneuver, the potential route for infection spread from the driveli-
ne exit wound to the device pocket is significantly extended.
The heart is allowed to fill with blood and the device is de-aired through its 
outflow part. The previously de-aired outflow graft is then attached and secured to 
the device body. An additional venting hole is placed in the outflow graft. The com-
plete evacuation of air is confirmed with transesophageal echocardiography and the 
device is started. The patient is then weaned from the CPB. 
We routinely place a Gore-tex pericardial membrane over the anterior mediasti-
nal structures and secure it to the pericardial edges to minimize the risk of injury 
during the planned reoperative sternotomy. Chest tubes are placed in the opened 
pleural cavities and in the mediastinum – next to the apical inflow cannula and 
LVAD pocket, and retrosternally, over the pericardial membrane. After the hemosta-
sis is achieved, the chest is closed in the standard fashion.
Bleeding prevention
Excessive mediastinal bleeding is common after mechanical circulatory sup-
port device implantation, occurring in up to 40% of patients; it can lead to massive 
transfusions and re-exploration. Many risk factors predispose excessive bleeding in 
this subset of patients, including the compromised nutritional status and hepatic 
dysfunction due to chronic heart failure; extensive surgical dissection; reoperations; 
prolonged cardiopulmonary bypass; and coagulopathy, due to interactions between 
the circulating blood and the artificial surfaces. 
Therefore, a special attention should be paid to the meticulous hemostasis of all 
surfaces. Some of the procedural steps, such as pocket creation and driveline tunne-
ling, should be done prior to the heparin administration. We also routinely use a 
cell saver for intraoperative blood salvage, administer tranexamic acid in optimal 
doses to efficiently inhibit fibrinolysis, and use fibrin glue to reinforce suture lines. 
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Thromboelastography is routinely used both preoperatively and after the protami-
ne administration to guide the possible coagulopathy treatment.
Right ventricular failure prevention
Right ventricular failure is a dreaded complication after the VAD implantati-
on, with an extremely high mortality (up to 40%). Some intraoperative measures 
also contribute to the right ventricular failure prevention. Mean arterial perfusion 
pressure during implantation should be kept above a mean of 70 mmHg to provide 
the RV protection. Cardioplegic arrest should be used only in selected cases. The 
left ventricle, the assist device, the outflow graft and the ascending aorta should be 
meticulously de-aired to avoid a possible air embolization of right coronary artery. 
Excessive bleeding and massive transfusions impair the right ventricular function; 
it should therefore be avoided at all costs. Finally, left ventricular assist device speed 
should be adjusted to prevent an excessive shifting of the interventricular septum to 
the left side, which regularly impairs the right ventricular function.
Infection control
Clinical experience has shown that the LVAD infection rates can be minimi-
zed by optimizing the implant techniques and wound care; appropriate antibiotic 
prophylaxis; avoiding infections in indwelling catheters; maximizing patients’ nu-
tritional status; and optimizing glycemic control. There are several additional intra-
operative and postoperative considerations that are important for infection control. 
The size of the preperitoneal device pocket should be minimized, whilst the length 
of the driveline passed through the abdominal wall muscle should be maximized. 
The sterility of all implantable materials should be vigorously monitored, while the 
number of people circulating the operating room should be limited to the neces-
sary minimum. It is of utmost importance to immobilize the percutaneous driveline 
exit site, possibly by using an additional 2-point holder or a stabilization belt. Po-
stoperatively, the exit wound dressing should be changed daily through the initial 
weeks, and subsequently on a 2- or a 3-day basis. The wound should be cared with 
chlorhexidine. Any signs of exit wound infection should be aggressively treated by 
daily re-dressing using hydrogen peroxide and povidone-iodine, combined with a 
targeted antibiotic therapy. 
17
Rad 509. Medical Sciences 36(2011) : 13-17
D. Barić et al: Long-term mechanical circulatory support: surgical techniques
References
[1] Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, Starling RC, 
Chen L, Boyle AJ, Chillcott S, Adamson RM, Blood MS, Camacho MT, Idrissi KA, 
Petty M, Sobieski M, Wright S, Myers TJ, Farrar DJ. HeartMate II Clinical Investi-
gators. Clinical management of continuous-flow left ventricular assist devices 
in advanced heart failure. J Heart Lung Transplant. 2010 Apr;29(4 Suppl):S1-39.
[2] Aggarwal S, Cheema F, Oz MC, Naka Y. Long-Term Mechanical Circulatory Sup-
port in Cardiac Surgery in the Adult, 3rd ed. Cohn LH (Ed); McGraw-Hill Medical: 
New York, 2007; pp. 1609-1628. 
[3] Mancini D, Burkhoff D. Mechanical device-based methods of managing and 
treating heart failure. Circulation 2005; 112: 438.
[4] Park SJ, Tector A, Piccioni W, et al. Left ventricular assist device as destination 
therapy: a new look at survival. J Thorac Cardiovasc Surg 2005; 129:9.
[5] Kormos RL, Teuteberg JJ, Pagani FD, et all. Right ventricular failure in patients with 
the HeartMate II continuous-flow left ventricular assist device: incidence, risk fac-
tors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010 May;139(5):1316-24.
[6] Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles 
AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH. 
HeartMate II Investigators. Advanced heart failure treated with continuous-flow 
left ventricular assist device. N Engl J Med. 2009 Dec 3;361(23):2241-51.
[7] Holman WL, Park SJ, Long JW, et al. Infection in permanent circulatory support: 
experience from the REMATCH trial. J Heart Lung Transplant 2004; 23:1359.
Sažetak
Dugotrajna mehanička potpora cirkulaciji: kirurške tehnike
Dugotrajna mehanička potpora cirkulaciji postala je provjerena metoda u liječenju završne 
faze srčanog zatajenja. Kod odabranih bolesnika, dokazano je da poboljšava preživljenje, bilo 
kao potpora do transplantacije ili destinacijske terapije. U članku opisujemo  tehnike ugradnje, 
strategije u cilju smanjenja prekomjernog krvarenja, zatajenja desnog srca te infekcije oko mjesta 
izlaska kabela za napajanje.
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